Personalized Medicine - The Genomic Revolution in Ca... (ersonalized cardiovascular care. Researc...)

Personalized Medicine - The Genomic Revolution in Cardiac Care

Date:9/19/2007

ersonalized cardiovascular care. Researchers, cardiologists, policy makers, medical industry and anyone with an interest in personalized medicine and genomics will want to attend.

"By identifying the genes that can cause and cure heart disease, researchers hold in their hands the potential for personalized medicine. Understanding research advances in the science of the human gene and its application to cardiovascular disease will make possible life saving changes in cardiac care," says Dr. Timothy McCaffrey, who is the program co-chair for the one-day symposium as well as director of the McCormick Genomics Center at The George Washington University. The McCormick Genomics Center is among the nation's innovative leaders in genomics research and application and is one of the few centers in the world to focus on cardiovascular genomic research. Dr. McCaffrey will lead a faculty of renowned experts, in the program.

"Leveraging the enormous resources of The George Washington University is a key part of how the Institute is approaching its mission to accelerate the pace of scientific discovery, reduce mortality and improve the quality of life of Americans with cardiovascular disease," said Dr. Richard J. Katz, who is the Director of the Cheney Cardiovascular Institute and Director of the Division of Cardiology. "An educational program like this one, on personalized medicine in cardiac care, holds the key to the next major advancements in cardiovascular care, which researchers, clinicians and policy makers must understand is one of the ways we're attacking cardiovascular disease and working to achieve our mission."

The symposium, titled "Personalized Medicine: The Genomic Revolution in Cardiac Care," is designated for 6 AMA PRA Category 1 Credits and will convene on October 25, 2007 at The George Washington University Hospital Auditorium, in Washington, DC. For more information about the symposium or to register, please visit

SOURCE The Cheney Cardiovascular Institute
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine technology :

1. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
2. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
3. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
4. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
5. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
6. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
9. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
10. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
11. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine

Post Your Comments:

(Date:12/14/2009)... 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. ... had received a complete response letter from the ... its New Drug Application ("NDA") for Onrigin(TM) (laromustine) ... indicates that the FDA cannot approve the Company,s ... to address remaining issues. ,, Alan Kessman, Chief ...

(Date:12/14/2009)... Cancer patients in Finland have gained access to ... radiotherapy technology from Varian Medical Systems (NYSE: ... clinic in the Nordic region. Clinicians at Docrates ... precise form of radiotherapy to treat patients with ... and prostate. ,, RapidArc, which enables clinicians to ...

(Date:12/14/2009)... 14 According to Millennium Research Group ... intelligence, increased use of safety devices for small-bore ... a key driver of the enteral feeding device ... new US and European Markets for Enteral ... giving set segment will experience the greatest impact ...

[0] Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration [0] Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments [0] Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014

... fair coloring traits contribute to risk, of skin cancer; ... REYKJAVIK, Iceland, May 18 In two papers published,today, ... U.S.,expand upon the company,s recent findings in the genetics ... that certain of these,common variants also confer risk of ...

... and under-studied population ... important insights -, SAN DIEGO, Calif., May 18 ... largest prospective study to evaluate the,response of Latino whites ... therapy with pegylated interferon plus ribavirin. The,results showed PEGASYS(R) ...

Other Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2 deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3 deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 2 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 3 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 4 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 5 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 6 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 7 PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 8

deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C

(Date:12/14/2009)... YORK, Dec. 14 Josie Raper, a 29 year-old ... in six months with the help of the Dr. Siegal,s ... on the Joy Fit Club segment on NBC,s Today Show. ... Joy Bauer, airs twice a month and salutes those who ... in 2007 and has kept it off for two years. ...

(Date:12/14/2009)... Athens, Ga. A new study published by researchers ... Center in Tampa, Fla., has found that cancer patients ... patients with cancer alone, even after controlling for factors ... But the study, published in the early online edition ... also argues that a diagnosis of dementia shouldn,t discourage ...

(Date:12/14/2009)... of medication-related problems, including under treatment, suboptimal drugs, suboptimal ... their quality of life. Now new research (1), from ... of North Carolina at Chapel Hill shows that blacks ... medical regimens is a particular issue for this group. ... disparities in the quality of medication use appears this ...

(Date:12/14/2009)... clothing supplier, MPE, offers protective garments online to military and ... ... Hammond, Ind. (PRWEB) December 14, 2009 -- Miller,s Precision ... garments , announces its recent approval as a vendor on ... approved DOD EMALL vendor, MPE can provide military, government and ...

(Date:12/14/2009)... Racial disparities seen for ,standard-of-care, breast cancer treatment, study ... new study finds a significant racial disparity in breast ... white counterparts to receive radiation therapy after a lumpectomy. ... care for the treatment of breast cancer that is ... published in the Dec. 14 issue of the journal ...

Breaking Medicine News(10 mins):Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2 Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3 Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4 Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 2 Health News:Study finds significantly worse outcomes in cancer patients with cognitive impairment 3 Health News:Racial differences in medication use 2 Health News:MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL 2 Health News:After Lumpectomy, Radiation Rates Lower for Black Women 2

[0] Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club [0] Study finds significantly worse outcomes in cancer patients with cognitive impairment [0] Racial differences in medication use [0] MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL [0] After Lumpectomy, Radiation Rates Lower for Black Women

... Disease Patients Rising, CHICAGO, April 2 ... disease and, according to the latest research,from Prevent ... number,is continuing to climb. With more than 130 ... million suffer from leading causes of vision loss ...

... Ready for Action on the House Floor, WASHINGTON, ... Bernadette A. Toomey, President and CEO, American Lung,Association:, ... Energy and Commerce Committee for its passage of the ... urge the full,House to quickly take action to move ...

... more, it predicts major episodes, study finds , , WEDNESDAY, ... in young adults can increase their risk of developing ... of almost 600 young adults found that those with ... sleeplessness gradually increased over two decades, especially among women. ...

... would welcome an advance promising to dramatically reduce their ... at Washington University School of Medicine in St. Louis ... The researchers focused a powerful drug directly on tumors ... drug dose 1,000 times lower than used previously for ...

... Sebring Convertible Winner To Be Part Of Live Auction At ADA,s ... Annual Gala At Ritz-Carlton Dearborn, Donation By Chrysler Jeep Superstores Will Help Children ... ... Diabetes research,advocacy and education received a big boost thanks to the generous ...

... are running for president or looking for a clerical ... are a woman, Yale University psychologist Victoria Brescoll has ... recently completed three separate studies to explore a phenomenon ... Senator Hillary Clinton: People accept and even reward men ...

Other Medicine News:Health News:Eye Disease Continuing to Increase Among Americans 2 Health News:Eye Disease Continuing to Increase Among Americans 3 Health News:Persistent Insomnia Leads to Depression in Young Adults 2 Health News:Nano-sized technology has super-sized effect on tumors 2 Health News:Nano-sized technology has super-sized effect on tumors 3 Health News:Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible 2 Health News:Studies' message to women: Keep your cool 2

Eye Disease Continuing to Increase Among Americans American Lung Association Applauds Energy and Commerce Committee for its Strong Commitment to Protecting Public Health From the Dangers of Tobacco Persistent Insomnia Leads to Depression in Young Adults Nano-sized technology has super-sized effect on tumors Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible Studies' message to women: Keep your cool

1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...

... By combining intra-operative ultrasound ... Medtronic Surgical Navigation Technologies ... product called SonoNav Intra-operative ... built on the high ...

... Bioglue Surgical Adhesive (Bioglue) is a ... bovine serum albumin (BSA) and glutaraldehyde. ... exclusively from bovine spongiform encephalopathy (BSE) ... reduces or inactivates viruses. The solutions ...

... Cebus is Plasmaseal's low cost, low volume ... and the plasma is separated from whole blood ... plasma is transferred to the Cebus single use ... for 30 seconds to activate the concentrating process. ...

Medicine Products:

Delta System Sononav Intraoperative Imaging System Bioglue Cebus

Personalized Medicine - The Genomic Revolution in Ca...(ersonalized cardiovascular care. Researc...),Health